William M. Sallas

1000 total citations
19 papers, 758 citations indexed

About

William M. Sallas is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, William M. Sallas has authored 19 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Physiology. Recurrent topics in William M. Sallas's work include Diabetes Treatment and Management (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Allergic Rhinitis and Sensitization (2 papers). William M. Sallas is often cited by papers focused on Diabetes Treatment and Management (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Allergic Rhinitis and Sensitization (2 papers). William M. Sallas collaborates with scholars based in United States, Switzerland and Japan. William M. Sallas's co-authors include James E. Foley, Monica Ligueros‐Saylan, Yanling He, C. E. Watson, Beth E. Dunning, Philip J. Lowe, Andrea Mari, Carolyn F. Deacon, Jens J. Holst and Yuko Tsukamoto and has published in prestigious journals such as Journal of the American Statistical Association, The Journal of Clinical Endocrinology & Metabolism and Journal of Allergy and Clinical Immunology.

In The Last Decade

William M. Sallas

19 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William M. Sallas United States 10 309 194 177 162 81 19 758
Pamela F. Schwartz United States 15 99 0.3× 102 0.5× 344 1.9× 42 0.3× 41 0.5× 35 889
Weixiong Lin China 16 163 0.5× 199 1.0× 174 1.0× 45 0.3× 35 0.4× 55 756
Jau‐Tsuen Kao Taiwan 18 350 1.1× 210 1.1× 406 2.3× 46 0.3× 53 0.7× 50 1.1k
Maria Stella Graziani Italy 15 161 0.5× 281 1.4× 145 0.8× 68 0.4× 15 0.2× 43 826
Carmen H. Tong United States 15 119 0.4× 183 0.9× 323 1.8× 29 0.2× 33 0.4× 32 1.1k
Shi Tai China 17 177 0.6× 214 1.1× 180 1.0× 55 0.3× 7 0.1× 53 837
Markus Wallner Austria 17 181 0.6× 355 1.8× 184 1.0× 68 0.4× 11 0.1× 61 965
L Giroux Canada 15 99 0.3× 96 0.5× 248 1.4× 89 0.5× 190 2.3× 31 829
Renée Benghozi Switzerland 13 103 0.3× 156 0.8× 277 1.6× 48 0.3× 17 0.2× 23 616
Ronald Goldwater United States 12 69 0.2× 136 0.7× 79 0.4× 37 0.2× 29 0.4× 32 708

Countries citing papers authored by William M. Sallas

Since Specialization
Citations

This map shows the geographic impact of William M. Sallas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. Sallas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. Sallas more than expected).

Fields of papers citing papers by William M. Sallas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. Sallas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. Sallas. The network helps show where William M. Sallas may publish in the future.

Co-authorship network of co-authors of William M. Sallas

This figure shows the co-authorship network connecting the top 25 collaborators of William M. Sallas. A scholar is included among the top collaborators of William M. Sallas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William M. Sallas. William M. Sallas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhu, Penny, et al.. (2018). Population pharmacokinetics–pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex. Journal of Pharmacokinetics and Pharmacodynamics. 45(5). 707–719. 11 indexed citations
2.
Wire, Mary Beth, Xiaobin Li, Jianping Zhang, et al.. (2018). Modeling and Simulation Support Eltrombopag Dosing in Pediatric Patients With Immune Thrombocytopenia. Clinical Pharmacology & Therapeutics. 104(6). 1199–1207. 11 indexed citations
3.
Giles, Francis J., Ophelia Yin, William M. Sallas, et al.. (2012). Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia. European Journal of Clinical Pharmacology. 69(4). 813–823. 67 indexed citations
4.
Borrmann, Steffen, William M. Sallas, Sónia Machevo, et al.. (2010). The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem®) for acute uncomplicatedPlasmodium falciparummalaria. Tropical Medicine & International Health. 15(4). 434–41. 43 indexed citations
5.
Blumer, Jeffrey L., et al.. (2010). Single-Dose Pharmacokinetics of Famciclovir in Infants and Population Pharmacokinetic Analysis in Infants and Children. Antimicrobial Agents and Chemotherapy. 54(5). 2032–2041. 8 indexed citations
6.
Zhou, Xiao‐Jian, et al.. (2009). Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment. The Journal of Clinical Pharmacology. 49(6). 725–734. 3 indexed citations
7.
Habtemariam, Bahru, William M. Sallas, Gangadhar Sunkara, et al.. (2009). Population Pharmacokinetics of Valsartan in Pediatrics. Drug Metabolism and Pharmacokinetics. 24(2). 145–152. 11 indexed citations
8.
Slavin, Raymond G., et al.. (2007). Exploring the Effect on Asthma Control of Omalizumab Reduction After 28 Weeks Treatment. Journal of Allergy and Clinical Immunology. 119(1). S308–S308. 2 indexed citations
9.
Tsukamoto, Yuko, et al.. (2006). A mechanism‐based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab. British Journal of Clinical Pharmacology. 63(5). 548–561. 141 indexed citations
10.
He, Yanling, et al.. (2006). Vildagliptin Does Not Affect C‐Peptide Clearance in Patients With Type 2 Diabetes. The Journal of Clinical Pharmacology. 47(1). 127–131. 5 indexed citations
11.
Mari, Andrea, William M. Sallas, Yanling He, et al.. (2005). Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 90(8). 4888–4894. 324 indexed citations
12.
He, Yanling, Ann D. Horowitz, C. E. Watson, et al.. (2005). Lack of effect of LAF237 on C-peptide clearance in patients with type 2 diabetes. Clinical Pharmacology & Therapeutics. 77(2). P56–P56. 5 indexed citations
13.
Sallas, William M.. (2003). Pharmacokinetic drug interactions in children taking oxcarbazepine. Clinical Pharmacology & Therapeutics. 74(2). 138–149. 39 indexed citations
14.
Sallas, William M., et al.. (1995). A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients. Journal of Pharmacokinetics and Biopharmaceutics. 23(5). 495–514. 6 indexed citations
15.
Sallas, William M.. (1995). Development of limited sampling strategies for characteristics of a pharmacokinetic profile. Journal of Pharmacokinetics and Biopharmaceutics. 23(5). 515–529. 9 indexed citations
16.
Sallas, William M. & Helmuth Späth. (1993). Mathematical Algorithms for Linear Regression.. Journal of the American Statistical Association. 88(421). 376–376. 27 indexed citations
17.
Sallas, William M.. (1988). Remark AS R75: Some Remarks on Algorithm AS 164: Least Squares Subject to Linear Constraints. Journal of the Royal Statistical Society Series C (Applied Statistics). 37(3). 484–484. 1 indexed citations
18.
Sallas, William M. & David A. Harville. (1981). Best Linear Recursive Estimation for Mixed Linear Models. Journal of the American Statistical Association. 76(376). 860–869. 40 indexed citations
19.
Sallas, William M. & David A. Harville. (1981). Best Linear Recursive Estimation for Mixed Linear Models. Journal of the American Statistical Association. 76(376). 860–860. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela F. Schwartz Breakdown of academic impact, for papers by Weixiong Lin Breakdown of academic impact, for papers by Jau‐Tsuen Kao Breakdown of academic impact, for papers by Maria Stella Graziani Breakdown of academic impact, for papers by Carmen H. Tong Breakdown of academic impact, for papers by Shi Tai Breakdown of academic impact, for papers by Markus Wallner Breakdown of academic impact, for papers by L Giroux Breakdown of academic impact, for papers by Renée Benghozi Breakdown of academic impact, for papers by Ronald Goldwater
Rankless by CCL
2026